Cantitate/Preț
Produs
Total produse
Vezi coșul
Pharmaceutical Stability Testing to Support Global Markets de Kim Huynh-Ba

Pharmaceutical Stability Testing to Support Global Markets: Biotechnology: Pharmaceutical Aspects, cartea XII

Editat de Kim Huynh-Ba
en Limba Engleză Paperback – 25 feb 2012
The International Conference of Harmonization (ICH) has worked on har- nizing the stability regulations in the US, Europe, and Japan since the early 1990s. Even though the Stability Guidelines Q1A (R2) was issued over a decade ago, issues surrounding this arena continue to surface as the principles described in the guideline are applied to different technical concentrations. As a result, the stability community has continued to discuss concerns and find ways of harmonizing regulatory requirements, streamlining practices, improving processes in order to bring safe and effective medical supplies to the patients around the world. In 2007, the American Association of Pharmaceutical Scientists (AAPS) Stability Focus Group organized two workshops – the Stability Workshop and the Degradation Mechanism Workshop. These meetings attracted many industry scientists as well as representatives from several regulatory agencies in the world to discuss important topics related to pharmaceutical stability practices. Recognizing the importance of documenting these discussions and with the permission of AAPS, I have worked with speakers to assemble a collection of 30 articles from presentations given at these two meetings, mainly the Stability Workshop. I trust that this book will be beneficial to all of you in providing guidance and up-to-date information for building quality stability programs. v Freedom of our mind is Mother of all inventions.
Citește tot Restrânge

Toate formatele și edițiile

Toate formatele și edițiile Preț Express
Paperback (1) 107545 lei  6-8 săpt.
  Springer – 25 feb 2012 107545 lei  6-8 săpt.
Hardback (1) 108246 lei  6-8 săpt.
  Springer – 17 dec 2009 108246 lei  6-8 săpt.

Din seria Biotechnology: Pharmaceutical Aspects

  • 5% Pharmaceutical Profiling in Drug Discovery for Lead Selection
    Preț: 159159 lei
  • 5% Methods for Structural Analysis of Protein Pharmaceuticals
    Preț: 191458 lei
  • 5% Optimizing the "Drug-Like" Properties of Leads in Drug Discovery
    Preț: 140494 lei
  • 5% Advances in Bioactivation Research
    Preț: 140580 lei
  • 5% Prodrugs: Challenges and Rewards
    Preț: 329368 lei
  • 5% Solvent Systems and Their Selection in Pharmaceutics and Biopharmaceutics
    Preț: 158981 lei
  • 5% Drug Absorption Studies: In Situ, In Vitro and In Silico Models
    Preț: 141745 lei
  • 5% Immunogenicity of Biopharmaceuticals
    Preț: 108499 lei
  • 5% Nanotechnology in Drug Delivery
    Preț: 160449 lei
  • 18% Current Trends in Monoclonal Antibody Development and Manufacturing
    Preț: 125287 lei

Preț: 107545 lei

Preț vechi: 113206 lei
-5% Nou

Puncte Express: 1613
Preț estimativ în valută:
20589€ • 21401$ • 17070£

Carte tipărită la comandă

Livrare economică 06-20 februarie 25

 Adaugă în coș

Wish list
Gift list
Am citit!
Adaugă în listă
Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9781461425366
ISBN-10: 1461425360
Pagini: 288
Ilustrații: XX, 266 p. 11 illus., 4 illus. in color.
Dimensiuni: 178 x 254 x 15 mm
Greutate: 0.5 kg
Ediția:2010
Editura: Springer
Colecția Springer
Seria Biotechnology: Pharmaceutical Aspects

Locul publicării:New York, NY, United States

Public țintă

Research

Cuprins

Section I.- Stability Studies in a Global Environment.- Regulatory Perspectives on Product Stability.- Current International Harmonization Efforts.- Update on the WHO Stability Guideline.- Development of a Regional Guideline for the Eastern Mediterranean Region.- The Challenge of Diverse Climates: Adequate Stability Testing Conditions for India.- Requirements for South East Asian Markets.- The Role of USP Monographs in Stability Testing.- Regulatory Requirements for Stability Testing of Generics.- Stability Design for Consumer Healthcare Products.- Challenges of Drug/Devices Pharmaceutical Products.- Practical Challenges of Stability Testing of Nutraceutical Formulations.- Setting Tolerances for Instrument Qualification USP Chapter .- Technical Concepts for Stability Program.- The Concept of Quality-by-Design.- Forced Degradation and Its Relation to Real Time Drug Product Stability.- Low Level Impurities in Drug Substances and Drug Products and the Analytical Challenges in Identification and Quantitation.- Stability of Repackaged Products.- Packaging-Induced Interactions and Degradation.- An Overview of Physical Stability of Pharmaceuticals.- Stability of Split Tablets.- Temperature Monitoring During Shipment and Storage.- Introducing a Science-Based Quality by Design Concept to Analytical Methods Development.- Stability Data and Operational Practices.- Optimizing Stability Data Package to Facilitate NDA/MAA Approval.- Maximize Data for Post Approval Changes.- Use of Statistics to Establish a Stability Trend: Matrixing.- Setting Specifications for Drug Substances.- Setting Specifications for Drug Products.- Highlights of Investigating Out-of-Specifications Test Results.- Strategies for Ensuring Regulatory and cGMP Compliance of Outsourced Stability Programs.- Building and Developing of Relationships with Third Party Laboratories.- Outsourcing Stability Testing: A Tool for Resource and Risk Management.

Notă biografică

Kim Huynh-Ba is the founder and Technical Director of Pharmalytik (www.pharmalytik.com). She has twenty two years of experience in various analytical areas of pharmaceutical development and a primary focus in stability sciences. Prior to Pharmalytik, she held positions in drug development at Astra Zeneca (formerly ICI Americas), DuPont Merck, DuPont Pharmaceuticals, Bristol Myers Squibb and Wyeth Vaccines. She has been advising pharmaceutical companies including companies operating under Consent Decree on harmonization and optimization of analytical best practices since 2001.
In addition to her consulting activities, Kim is a short course instructor and organizer on topics ranging from cGMP compliance and quality issues to stability programs under sponsorship of global organizations such as American Chemical Society (ACS), American Association of Pharmaceutical Scientists (AAPS), Pittsburgh Conference, many other international training groups. She is the founder and past co-chair of the AAPS Stability Focus Group, and an active member of the Pharmaceutical Stability Discussion Group (PSDG). She serves on the Governing Board of Eastern Analytical Symposium (EAS). She currently is Chair of the AAPS APQ e-Learning Committee and the 2008 EAS Short Course Program. She is a member of USP's Prescription/Non-Prescription Stakeholder Forum and also USP Reference Standard Project Team.
Kim Huynh-Ba is a recipient of the 2008 AAPS APQ Service Award and 2008 Recognition Award of AAPS Regulatory Section. She also received the 2001 DPCAA Leadership Award.
Kim Huynh-Ba has authored numerous technical publications and book chapters. She is invited frequently to present at national and international conferences. She is the editor of the Handbook of Stability Testing in Pharmaceutical Development: Regulations, Methodologies and Best Practices, which has been recognized as a practical reference book in the stability community.

Caracteristici

Provides an understanding of the regulatory perspective of Stability Testing and position the stability program for 21st century globally Comprises several sessions organized in dual tracks to explore different stability related challenges, such as monitoring impurities, evaluating shipping excursions, setting specifications, estimating expiry Stability is a crucial sector of the Drug Development Process. Companies rely on the stability data to establish an expiry for marketed pharmaceutical products. Many guidelines have been developed around this arena; however, many issues are continued to raise and challenge our practices

Descriere

Descriere de la o altă ediție sau format:

Stability testing in challenging storage environment such as ASEAN or Caribbean region.Exploring concept of Quality by Design as it applies to stability testing.Understanding stability challenges of biologics, generics, nutraceutical, and other new product technology.Setting specifications for Drug Substances as well as various type of drug products.Exploring concerns on changes of stability profiles such as repackaged products, split tablets.Discussing safety and toxicology concerns of emerging impurities.Understanding physical effects on product stability.Stability to support temperature excursion during shipping.Assessing impurities and degradation product in development.Leveraging stability data to expedite regulatory approval.Managing relationship with Contract Research Organizations.